Orphan Drugs for Rare Diseases Steven SimoensDavid CassimanEline Picavet Current Opinion 06 January 2012 Pages: 1437 - 1443
Therapeutic Potential of Mipomersen in the Management of Familial Hypercholesterolaemia Carmen GelsingerElisabeth Steinhagen-ThiessenUrsula Kassner Leading Article 06 January 2012 Pages: 1445 - 1455
Delirium in Critically Ill Patients Irene J. ZaalArjen J. C. Slooter Therapy In Practice 06 January 2012 Pages: 1457 - 1471
Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections Thomas P. LodiseDonald E. Low Review Article 06 January 2012 Pages: 1473 - 1493
Ten Years of Experience with Biphasic Insulin Aspart 30 Andreas LieblVinay PrustyViswanathan Mohan Review Article Open access 06 January 2012 Pages: 1495 - 1520
Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis Lin-lin LiuYi JiangZi-long Li Systematic Review 06 January 2012 Pages: 1521 - 1533
A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [VepacelĀ®] Greg L. Plosker Adis Drug Profile 06 January 2012 Pages: 1543 - 1557
Erratum to Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia G. M. Keating Erratum 06 January 2013 Pages: 1578 - 1578